Genetic or pharmacological impairment of Gadd34 in S63del nerves, which should increase eIF2alpha phosphorylation, and reduce the synthesis of P0S63del, fully rescued this neuropathy phenotype (D’Antonio et al., 2013; Das et al., 2015). This evidence concerns the gene EIF2S1 and neuropathy.